AVANDARYL - 0173-0844-13 - (rosiglitazone maleate and glimepiride)

Alphabetical Index


Drug Information of AVANDARYL

Product NDC: 0173-0844
Proprietary Name: AVANDARYL
Non Proprietary Name: rosiglitazone maleate and glimepiride
Active Ingredient(s): 2; 8    mg/1; mg/1 & nbsp;   rosiglitazone maleate and glimepiride
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of AVANDARYL

Product NDC: 0173-0844
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021700
Marketing Category: NDA
Start Marketing Date: 20110524

Package Information of AVANDARYL

Package NDC: 0173-0844-13
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE (0173-0844-13)

NDC Information of AVANDARYL

NDC Code 0173-0844-13
Proprietary Name AVANDARYL
Package Description 30 TABLET, FILM COATED in 1 BOTTLE (0173-0844-13)
Product NDC 0173-0844
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name rosiglitazone maleate and glimepiride
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20110524
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name GLIMEPIRIDE; ROSIGLITAZONE MALEATE
Strength Number 2; 8
Strength Unit mg/1; mg/1
Pharmaceutical Classes Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient]

Complete Information of AVANDARYL


General Information